(-)-epigallocatechin 3-gallate decreases expression ISO RGD:733855 6480464 epigallocatechin gallate results in decreased expression of XRCC5 protein CTD PMID:31195006 (-)-quinic acid multiple interactions ISO RGD:733855 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC5 mRNA CTD PMID:21751221 (S)-naringenin multiple interactions ISO RGD:733855 6480464 [naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA CTD PMID:36235125 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of XRCC5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of XRCC5 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:733855 6480464 Estradiol results in increased expression of XRCC5 mRNA CTD PMID:16514628 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:733855 6480464 Metribolone results in decreased expression of XRCC5 protein CTD PMID:17152098 2,2'-dithiodiethanol multiple interactions ISO RGD:733855 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin affects the methylation of XRCC5 intron] which results in decreased expression of XRCC5 mRNA CTD PMID:33017471 2,6-dinitrotoluene affects expression ISO RGD:3976 6480464 2, 6-dinitrotoluene affects the expression of XRCC5 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression ISO RGD:3976 6480464 alpha-Chlorohydrin results in increased expression of XRCC5 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of XRCC5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:733855 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of XRCC5 protein CTD PMID:34186270 4-amino-1,8-naphthalimide affects response to substance EXP 6480464 XRCC5 protein affects the susceptibility to 4-amino-1, 8-naphthalimide CTD PMID:16556909 4-amino-2,6-dinitrotoluene affects expression ISO RGD:3976 6480464 4-amino-2, 6-dinitrotoluene affects the expression of XRCC5 mRNA CTD PMID:21346803 4-hydroperoxycyclophosphamide decreases expression ISO RGD:3976 6480464 perfosfamide results in decreased expression of XRCC5 mRNA CTD PMID:11754170 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of XRCC5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:733855 6480464 Decitabine affects the expression of XRCC5 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO RGD:733855 6480464 XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] CTD PMID:18546291 afimoxifene decreases expression ISO RGD:733855 6480464 afimoxifene results in decreased expression of XRCC5 mRNA CTD PMID:16514628 aflatoxin B1 decreases methylation ISO RGD:733855 6480464 Aflatoxin B1 results in decreased methylation of XRCC5 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:733855 6480464 aflatoxin B2 results in increased methylation of XRCC5 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:733855 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 all-trans-retinoic acid increases expression ISO RGD:733855 6480464 Tretinoin results in increased expression of XRCC5 protein CTD PMID:20888851 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of XRCC5 mRNA CTD PMID:24489787 ammonium chloride affects expression ISO RGD:3976 6480464 Ammonium Chloride affects the expression of XRCC5 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:733855 6480464 aristolochic acid I results in decreased expression of XRCC5 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of XRCC5 mRNA CTD PMID:23650126 arsane increases expression ISO RGD:733855 6480464 Arsenic results in increased expression of XRCC5 protein CTD PMID:19818359 arsenic atom increases expression ISO RGD:733855 6480464 Arsenic results in increased expression of XRCC5 protein CTD PMID:19818359 arsenous acid increases expression ISO RGD:733855 6480464 Arsenic Trioxide results in increased expression of XRCC5 mRNA CTD PMID:22521957 atrazine decreases expression ISO RGD:733855 6480464 Atrazine results in decreased expression of XRCC5 mRNA CTD PMID:22378314 benzene increases expression EXP 6480464 Benzene results in increased expression of XRCC5 mRNA CTD PMID:15342939 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of XRCC5 mRNA CTD PMID:20504355 benzo[a]pyrene decreases methylation ISO RGD:733855 6480464 Benzo(a)pyrene results in decreased methylation of XRCC5 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:733855 6480464 Benzo(a)pyrene results in increased methylation of XRCC5 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733855 6480464 Benzo(a)pyrene results in increased expression of XRCC5 mRNA CTD PMID:28461126 biphenyl-4-amine multiple interactions ISO RGD:733855 6480464 Propolis inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 protein], TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 mRNA] CTD PMID:32905825 , PMID:33847444 biphenyl-4-amine decreases expression ISO RGD:733855 6480464 4-biphenylamine results in decreased expression of XRCC5 mRNA, 4-biphenylamine results in decreased expression of XRCC5 protein CTD PMID:32905825 , PMID:33847444 bisphenol A multiple interactions ISO RGD:733855 6480464 [naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA, bisphenol A inhibits the reaction [PRKDC protein binds to XRCC5 protein] CTD PMID:23227178 , PMID:36235125 bisphenol A decreases expression ISO RGD:733855 6480464 bisphenol A results in decreased expression of XRCC5 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:3976 6480464 bisphenol A results in decreased expression of XRCC5 mRNA CTD PMID:30816183 bisphenol A increases methylation ISO RGD:3976 6480464 bisphenol A results in increased methylation of XRCC5 gene CTD PMID:28505145 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of XRCC5 promoter CTD PMID:27334623 bisphenol A increases expression ISO RGD:3976 6480464 bisphenol A results in increased expression of XRCC5 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:733855 6480464 bisphenol B results in increased expression of XRCC5 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733855 6480464 bisphenol F results in increased expression of XRCC5 protein CTD PMID:34186270 bleomycin A2 affects response to substance ISO RGD:733855 6480464 XRCC5 protein affects the susceptibility to Bleomycin CTD PMID:12384553 cadmium atom multiple interactions ISO RGD:733855 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XRCC5 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:733855 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XRCC5 mRNA CTD PMID:35301059 caffeine decreases expression ISO RGD:733855 6480464 Caffeine results in decreased expression of XRCC5 protein CTD PMID:31195006 caffeine decreases phosphorylation ISO RGD:733855 6480464 Caffeine results in decreased phosphorylation of XRCC5 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:733855 6480464 Calcitriol results in decreased expression of XRCC5 mRNA CTD PMID:15951637 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:733855 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of XRCC5 mRNA CTD PMID:16039398 cisplatin multiple interactions ISO RGD:733855 6480464 XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] CTD PMID:18546291 cisplatin affects expression ISO RGD:733855 6480464 Cisplatin affects the expression of XRCC5 mRNA CTD PMID:23300844 clofibric acid multiple interactions ISO RGD:3976 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of XRCC5 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:733855 6480464 cobaltous chloride results in decreased expression of XRCC5 mRNA CTD PMID:19320972 , PMID:19376846 curcumin decreases expression ISO RGD:733855 6480464 Curcumin results in decreased expression of XRCC5 mRNA CTD PMID:17596214 cyproconazole multiple interactions ISO RGD:3976 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 D-glucose multiple interactions ISO RGD:733855 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 diarsenic trioxide increases expression ISO RGD:733855 6480464 Arsenic Trioxide results in increased expression of XRCC5 mRNA CTD PMID:22521957 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of XRCC5 mRNA CTD PMID:17361019 dicrotophos decreases expression ISO RGD:733855 6480464 dicrotophos results in decreased expression of XRCC5 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of XRCC5 mRNA CTD PMID:22467019 disodium selenite increases expression ISO RGD:733855 6480464 Sodium Selenite results in increased expression of XRCC5 mRNA CTD PMID:18175754 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of XRCC5 protein CTD PMID:24812279 doxorubicin decreases expression ISO RGD:733855 6480464 Doxorubicin results in decreased expression of XRCC5 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 [STAT3 gene mutant form results in increased susceptibility to Doxorubicin] which results in increased expression of XRCC5 protein more ... CTD PMID:24812279 endosulfan decreases expression ISO RGD:733855 6480464 Endosulfan results in decreased expression of XRCC5 mRNA CTD PMID:26722802 endosulfan decreases expression ISO RGD:3976 6480464 Endosulfan results in decreased expression of XRCC5 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:733855 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XRCC5 protein CTD PMID:23301498 epoxiconazole multiple interactions ISO RGD:3976 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 ethanol multiple interactions ISO RGD:3976 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of XRCC5 mRNA CTD PMID:17347304 etoposide affects response to substance ISO RGD:733855 6480464 XRCC5 protein affects the susceptibility to Etoposide CTD PMID:12384553 fenofibrate multiple interactions ISO RGD:3976 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of XRCC5 mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate increases expression ISO RGD:3976 6480464 Fenofibrate results in increased expression of XRCC5 mRNA CTD PMID:17264098 , PMID:18775883 finasteride increases expression ISO RGD:3976 6480464 Finasteride results in increased expression of XRCC5 mRNA CTD PMID:24136188 flutamide increases expression ISO RGD:3976 6480464 Flutamide results in increased expression of XRCC5 mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:3976 6480464 Flutamide results in decreased expression of XRCC5 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of XRCC5 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:733855 6480464 Formaldehyde results in decreased expression of XRCC5 mRNA CTD PMID:20655997 fulvestrant decreases expression ISO RGD:733855 6480464 fulvestrant results in decreased expression of XRCC5 mRNA CTD PMID:16514628 furan increases expression ISO RGD:3976 6480464 furan results in increased expression of XRCC5 mRNA CTD PMID:25539665 glucose multiple interactions ISO RGD:733855 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 hydrogen peroxide multiple interactions ISO RGD:733855 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC5 mRNA CTD PMID:21751221 hydroxyurea decreases expression EXP 6480464 Hydroxyurea results in decreased expression of XRCC5 mRNA CTD PMID:12929121 hydroxyurea increases mutagenesis EXP 6480464 Hydroxyurea results in increased mutagenesis of XRCC5 gene CTD PMID:16868089 irinotecan decreases expression ISO RGD:733855 6480464 Irinotecan analog results in decreased expression of XRCC5 mRNA CTD PMID:18927307 ivermectin decreases expression ISO RGD:733855 6480464 Ivermectin results in decreased expression of XRCC5 protein CTD PMID:32959892 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of XRCC5 mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:733855 6480464 Methyl Methanesulfonate results in decreased expression of XRCC5 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:733855 6480464 methylmercuric chloride results in decreased expression of XRCC5 mRNA CTD PMID:28001369 N-methyl-N-nitrosourea increases mutagenesis EXP 6480464 Methylnitrosourea results in increased mutagenesis of XRCC5 gene CTD PMID:16868089 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of XRCC5 mRNA CTD PMID:19690152 N-nitrosodiethylamine multiple interactions ISO RGD:3976 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of XRCC5 mRNA more ... CTD PMID:17602206 more ... nitrogen mustard affects response to substance ISO RGD:733855 6480464 XRCC5 protein affects the susceptibility to Nitrogen Mustard Compounds CTD PMID:10717383 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of XRCC5 mRNA CTD PMID:34911549 p-anisidine decreases expression EXP 6480464 4-anisidine results in decreased expression of XRCC5 mRNA CTD PMID:12929121 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of XRCC5 mRNA CTD PMID:12929121 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of XRCC5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:733855 6480464 Acetaminophen results in decreased expression of XRCC5 mRNA CTD PMID:21420995 , PMID:26497421 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of XRCC5 protein CTD PMID:26178269 phenethyl caffeate multiple interactions ISO RGD:3976 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of XRCC5 mRNA CTD PMID:20360939 picoxystrobin decreases expression ISO RGD:733855 6480464 picoxystrobin results in decreased expression of XRCC5 mRNA CTD PMID:33512557 piperonyl butoxide affects expression EXP 6480464 Piperonyl Butoxide affects the expression of XRCC5 mRNA CTD PMID:17014948 piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of XRCC5 mRNA CTD PMID:19690152 pirinixic acid increases expression ISO RGD:3976 6480464 pirinixic acid results in increased expression of XRCC5 mRNA CTD PMID:19162173 , PMID:20127075 prochloraz multiple interactions ISO RGD:3976 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 quercetin decreases expression ISO RGD:733855 6480464 Quercetin results in decreased expression of XRCC5 protein CTD PMID:19207037 raloxifene decreases expression ISO RGD:733855 6480464 Raloxifene Hydrochloride results in decreased expression of XRCC5 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:733855 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of XRCC5 mRNA CTD PMID:23557933 rotenone decreases expression ISO RGD:733855 6480464 Rotenone results in decreased expression of XRCC5 mRNA CTD PMID:33512557 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of XRCC5 protein CTD PMID:28918527 sulindac decreases expression ISO RGD:3976 6480464 Sulindac results in decreased expression of XRCC5 mRNA CTD PMID:24136188 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of XRCC5 mRNA CTD PMID:31919559 thioacetamide affects expression ISO RGD:3976 6480464 Thioacetamide affects the expression of XRCC5 mRNA CTD PMID:34492290 trichloroethene increases methylation ISO RGD:3976 6480464 Trichloroethylene results in increased methylation of XRCC5 gene CTD PMID:27618143 trichostatin A increases acetylation ISO RGD:733855 6480464 trichostatin A results in increased acetylation of XRCC5 protein CTD PMID:27064363 trichostatin A increases expression ISO RGD:733855 6480464 trichostatin A results in increased expression of XRCC5 mRNA CTD PMID:24935251 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of XRCC5 mRNA CTD PMID:19042947 valproic acid decreases expression ISO RGD:733855 6480464 Valproic Acid results in decreased expression of XRCC5 mRNA CTD PMID:23179753 , PMID:27188386 vorinostat decreases expression ISO RGD:733855 6480464 vorinostat results in decreased expression of XRCC5 protein CTD PMID:16928817 , PMID:20646843 wortmannin multiple interactions ISO RGD:733855 6480464 [wortmannin co-treated with docetaxel] results in decreased expression of XRCC5 protein CTD PMID:20878124